Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

RTA 408 cream protects mice from radiation skin damage.

CD206+ macrophages are crucial for hair growth in alopecia areata treatment.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

The humanized AA mouse model is better for testing new alopecia areata treatments.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

A specific group of skin stem cells was found to help maintain hair follicle cells.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.